New Two-Pronged attack tested against rare, aggressive melanomas
NCT ID NCT05546827
Summary
This study is testing if giving radiation therapy after starting immunotherapy drugs, but before surgery, can help shrink tumors and improve outcomes for patients with rare mucosal melanomas in the sinuses/nose or anus/rectum. It will enroll 40 adults whose cancer has not spread to other body parts. The main goal is to see how much of the tumor is killed by this combined approach before it is surgically removed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SINONASAL MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.